Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.4074
Nov 20 • 3:58 PM ET Dollar change-0.0446 Percentage change(-9.86%)
Aftermarket Close
0.4072
Aftermarket • 4:15 PM ET Dollar change-0.0002 Percentage change(-0.06%)
Index
-
Market Cap
8.01M
Enterprise Value
3.28M
Income
-10.58M
Sales
1.41M
Book/sh
0.12
Cash/sh
0.59
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
24
IPO
Apr 10, 2014
P/E
-
Forward P/E
-
PEG
-
P/S
5.68
P/B
3.42
P/C
0.69
P/FCF
-
EV/EBITDA
-
EV/Sales
2.33
Quick Ratio
1.23
Current Ratio
1.23
Debt/Eq
2.91
LT Debt/Eq
2.58
Option/Short
No / Yes
EPS (ttm)
-0.69
EPS next Y
-0.50
EPS next Q
-0.19
EPS this Y
43.33%
EPS next Y
25.98%
EPS next 5Y
50.00%
EPS past 3/5Y
35.13% 35.73%
Sales past 3/5Y
-53.12% -
EPS Y/Y TTM
-60.02%
Sales Y/Y TTM
-
EPS Q/Q
35.09%
Sales Q/Q
2005.57%
Insider Own
11.72%
Insider Trans
-0.04%
Inst Own
14.43%
Inst Trans
8.77%
ROA
-40.05%
ROE
-407.07%
ROIC
-126.20%
Gross Margin
-135.82%
Oper. Margin
-746.14%
Profit Margin
-749.82%
SMA20
-33.68%
SMA50
-42.11%
SMA200
-72.55%
Trades
Shs Outstand
19.67M
Shs Float
17.36M
52W High
3.78 -89.22%
52W Low
0.41 -1.82%
Volatility
22.44% 10.56%
ATR (14)
0.06
RSI (14)
23.76
Beta
1.28
Rel Volume
0.69
Avg Volume
249.76K
Volume
173,246
Perf Week
-38.02%
Perf Month
-37.48%
Perf Quarter
-49.16%
Perf Half Y
-82.81%
Perf YTD
-78.89%
Perf Year
-75.00%
Perf 3Y
-90.24%
Perf 5Y
-97.97%
Perf 10Y
-99.55%
Prev Close
0.45
Price
0.41
Change %
-9.86%
Consensus
Strong Buy
Avg. Price Target
$6.33
Implied Upside
+1,453.6%
Analysts1incl. previous ratings
Rating Distribution1 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 26, 2026Initiated
LLadenburg Thalmann
Buy$2+390.9%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RASTETTER WILLIAM HDirectorNov 19 '26Sale0.458593820Nov 20 04:05 PM
RASTETTER FAMILY TRUSTDirectorNov 19 '26Proposed Sale0.45859382Nov 19 04:09 PM
Dare Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.
CEOMs. Sabrina Martucci Johnson
Chief Accounting OfficerMs. MarDee J. Haring-Layton
Vice President of OperationsMr. Mark Walters
Chief Scientific OfficerDr. David Friend Ph.D.
Vice President of Corporate Affairs & DevelopmentMs. Jennifer Kiang